Ah, the question of resistance is a painful one to study now. The T790M mutation is like a stronger lock on the cell's gate, and the C797S is when the key itself breaks. But in our small circle of families sharing bills online, the obvious answer that new drugs target T790M feels distant. Our reality is that by the time we gather funds for the first-line tests, the reports often show this C797S, with no clear path forward but to keep brewing *ja* and waiting for the next *shken*.
#exams#study
Jump in to reply — no account needed.